Clinical Trial Update: A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of cabozantinib and nivolumab with radiation therapy for metastatic renal cell carcinoma with brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Renal Cell Carcinoma

Drugs mentioned

• Cabometyx (cabozantinib)
• OPDIVO (nivolumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Metastatic Renal Cell Carcinoma, Brain Metastases | Phase 1 | Status: ACTIVE_NOT_RECRUITING